Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation

Online download statistics by month:

Online download statistics by month: March 2020 to September 2022

	Abstract	Full	Pdf
Mar 2020	1941	865	843
Apr 2020	1705	1121	1095
May 2020	138	14	6
Jun 2020	147	9	2
Jul 2020	147	8	2
Aug 2020	134	5	2
Sep 2020	175	8	1
Oct 2020	134	9	1
Nov 2020	179	4	3
Dec 2020	674	24	20
Jan 2021	382	33	28
Feb 2021	83	16	13
Mar 2021	133	12	9
Apr 2021	255	14	11
May 2021	54	10	4
Jun 2021	17	10	6
Jul 2021	10	9	15
Aug 2021	13	12	7
Sep 2021	16	12	6
Oct 2021	107	16	5
Nov 2021	87	8	2
Dec 2021	157	16	7
Jan 2022	148	12	9
Feb 2022	75	7	2
Mar 2022	109	7	4
Apr 2022	100	11	4
May 2022	124	10	4
Jun 2022	80	4	0
Jul 2022	86	12	5
Aug 2022	140	11	3
Sep 2022	121	12	7
Total	7671	2321	2126